PATENT CLAIM ANALYSIS

Application Number: 15975733
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-11
Patent Classification: ["424", "456000"]

Abstract:
Disclosed herein is, among other things, a soft gel vaginal pharmaceutical composition and dosage form containing solubilized estradiol for the treatment of vulvovaginal atrophy (VVA) and female sexual dysfunction (FSD).

Claim (Index 16):
The method of  claim 14 , wherein the estradiol is solubilized.

Metadata:
- Claim Count in Document: 42.0
- Percentile: 93.0
- Lexical Diversity: 1.12121
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15975723', '15893546', '15372385', '15893542', '15893550']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8242199333625518
- 35 USC 102 Novelty (BERT): 0.6225317561516136
- Combined Prediction Score: 0.804051115641458
- Mean Citation Score: 594.3824280000001
- Max Citation Score: 696.49207
- Similarity Product: 508.2581396080506

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test